StockData
Vaxart, Inc. logo

Vaxart, Inc. (VXRT) income statement

VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$0.48+0.02 (+5.04%)

Close on Oct 19, 2026Market cap $115.15MP/E 3.2Yield –

Vaxart, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
16.3%
Net margin
15.9%
Return on equity, FY2025
22.3%

Financial strength

Current ratio
1.60
Debt to equity
–
Debt to assets
–
Cash to current liabilities
69.7%

Valuation

P/E ratio
3.2
Price to sales
0.47
Price to book
1.40
Dividend yield
–

See a number that looks wrong?